Increased levels of matrix metalloproteinase‐9 and interleukin‐8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients
- 17 February 2014
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (2) , 396-398
Abstract
No abstract availableFunding Information
- DEBRA
This publication has 10 references indexed in Scilit:
- MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa SimplexPLOS ONE, 2013
- Minocycline modulates cytokine and chemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibiting IκB kinase α/β phosphorylationTranslational Research, 2013
- Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literatureAmerican Journal of Physiology-Cell Physiology, 2010
- The specific proteolysis hypothesis of pemphigus: Does the song remain the same?Medical Hypotheses, 2007
- Defining the involvement of proteinases in pemphigus vulgaris: Evidence of matrix metalloproteinase‐9 overexpression in experimental models of diseaseJournal of Cellular Physiology, 2007
- Two Familial Cases of Epidermolysis Bullosa Simplex Successfully Treated With TetracyclineArchives of Dermatology, 1999
- A major role for neutrophils in experimental bullous pemphigoid.Journal of Clinical Investigation, 1997
- TETRACYCLINES FOR DYSTROPHIC EPIDERMOLYSIS BULLOSAThe Lancet, 1989
- MINOCYCLINE FOR DYSTROPHIC EPIDERMOLYSIS BULLOSAThe Lancet, 1989
- Tetracyclines inhibit tissue collagenase activityJournal of Periodontal Research, 1984